Mathieu Simon

Biography

 Mathieu Simon, MD, has served as Executive Vice-President since 2012, and as Chief Operating Officer since 2013. Dr. Mathieu Simon joined Cellectis Board of Directors in 2013. Prior to Cellectis, Dr. Simon was Senior Vice President Head of Global Pharmaceutical Operations at Pierre Fabre S.A. From 1994 to 2010, Dr. Simon has served at Wyeth Pharmaceuticals in both senior corporate and regional roles (Head of International Marketing and Medical Affairs and managing Director of several Wyeth Affiliates). Dr. Simon today is an advisor at the European Commission D.G. Research and Innovation. In addition to his Cellectis role, Dr. Simon is also Senior Strategic Advisor at Messier Maris Partners, an international investment-banking boutique located in New York, London and Paris and investment partner of Scientifica Capital located in Milan and Zurich. Dr Simon is also an independent director at Vaximm, a swiss german immuno-oncology company.

Research Interest

 Oncology